Answers are grounded in this paper and cite their sources.
Background: Atopic dermatitis ( Vicharchika ) is a chronic inflammatory skin disorder requiring a safe, standardized plant-based alternative to corticosteroid Ocimum basilicum ( Barbari ) shows kandughna (antipruritic), krimighna (antimicrobial), and vishaghna (antitoxic) properties, making it a viable candidate. Objective: This study aims to establish and evaluate the phytochemical standardization and fingerprint profile of the newly formulated Barbari gel to ensure reproducibility and therapeutic consistency. Materials and Methods: High-performance thin-layer chromatography (HPTLC) was used to establish the phytochemical fingerprint of Barbari gel and compare it with Barbari arka and raw herbal extracts. Methanolic test solutions (10 μL and 15 μL) were applied to silica gel 60 F254 plates. The mobile phase consisted of toluene: ethyl acetate: methanol: formic acid (3:3:2:1 v/v/v/v). Chromatograms were visualized at 254 nm and 366 nm, and data were processed using Vision CATS software with Savitzky-Golay smoothing and Gauss peak detection. Results: Distinct and reproducible chromatographic profiles were obtained. Barbari gel showed consistently a dominant peak at R f 0.80–0.81, indicating stable enrichment of flavonoids and phenolics. Barbari arka showed a sharp single peak at R f 0.92, suggesting eugenol dominance. The raw extract displayed multiple peaks between R f 0.77–0.97, reflecting chemical diversity. Conclusion: HPTLC fingerprinting validates Barbari gel as a reproducible and chemically consistent formulation, which is distinct from arka and raw extracts, confirming its quality for standardized dermatological care.
No takes yet. Share an insight, caveat, or question.
Parekh et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: